Atherosclerosis
Volume 168, Issue 2 , Pages 389-396, June 2003

Haptoglobin elutes from human atherosclerotic coronary arteries—a potential marker of arterial pathology

  • Maria A. Matuszek

      Affiliations

    • The Heart Research Institute, Sydney, Australia
  • ,
  • Lina P Aristoteli

      Affiliations

    • The Heart Research Institute, Sydney, Australia
  • ,
  • Paul G. Bannon

      Affiliations

    • The Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia
  • ,
  • Paul N. Hendel

      Affiliations

    • The Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia
  • ,
  • Clifford F. Hughes

      Affiliations

    • The Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia
  • ,
  • Wendy Jessup

      Affiliations

    • The Centre for Thrombosis and Vascular Research, University of New South Wales, Sydney, NSW 2052, Australia
  • ,
  • Roger T. Dean

      Affiliations

    • University of Canberra, ACT, Canberra, Australia
  • ,
  • Leonard Kritharides

      Affiliations

    • The Heart Research Institute, Sydney, Australia
    • The Centre for Thrombosis and Vascular Research, University of New South Wales, Sydney, NSW 2052, Australia
    • The Department of Cardiology, Concord Hospital, University of Sydney, Sydney, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-2-9385-1179; fax: +61-2-9385-1389

Received 27 June 2002; received in revised form 3 March 2003; accepted 8 April 2003.

Abstract 

Background: Molecules which egress from atherosclerotic arteries may function as plasma markers of arterial pathology, but such egress has not been proven with living human coronary arteries. We hypothesised that proteins eluting from the arterial wall may discriminate between atherosclerotic and non-atherosclerotic coronary arteries. Methods and results: During cardiac bypass surgery, 155 sequential fractions of antegradely flushed coronary cardioplegia solution were collected by balloon-cuffed catheter from the coronary sinus in subjects with angiographically extensive (n=30) or minor (n=7) coronary disease. Although plasma was the major source of protein in heavily blood-contaminated samples, under conditions of low blood contamination (<0.5 mg/ml red cell Haemoglobin) coronary circulation-derived protein was detected. N-terminal sequencing of a major 40 kDa band detected by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) demonstrated 100% homology with beta chain of Haptoglobin (Hpt). Comparison of perfusates from patients with and without significant coronary disease found that the concentration of Hpt was markedly increased in perfusates from atherosclerotic coronary arteries (0.099±0.017 μg Hpt/μg Hb) relative to controls (0.016±0.008 μg Hpt/μg Hb, P=0.0027). Analysis of peripheral plasma samples of the same subjects, and of a separate cohort of patients, confirmed greater Hpt in those with angiographic coronary disease than in those without disease. Conclusions: Proteins such as Hpt elute from the human coronary vascular bed and may differentiate between arteries with minor or extensive atherosclerosis. Although the suitability of Hpt as a circulating plasma marker for atherosclerosis remains to be established, the approach used in the present study may permit identification of diverse plasma-detectable markers of atherosclerosis, and the subsequent non-invasive evaluation of in vivo arterial pathology.

Keywords: Atherosclerosis, Coronary, Human, Haptoglobin, Artery, Biomarker, Diagnostic

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(03)00150-3

doi:10.1016/S0021-9150(03)00150-3

Atherosclerosis
Volume 168, Issue 2 , Pages 389-396, June 2003